Intercept Pharmaceuticals (ICPT) Debt/EBITDA US GAAP (year values)
FY2018 FY2019 FY2020 FY2021 FY2022   LTM ? CAGR 5 years ?
Debt/EBITDA 0.23 0.40 -0.46 -3.38 2.56   2.82  
Changes by years, y/y, % +30% +73% -215% +629% -176%     +70.3%
Compare with other companies

Intercept Pharmaceuticals. Debt/EBITDA

Intercept Pharmaceuticals. Debt/EBITDA, changes, %

Intercept Pharmaceuticals (ICPT) Debt/EBITDA US GAAP (quarter values)
FY2022Q3 FY2022Q4 FY2023Q1 FY2023Q2 FY2023Q3   LTM ?
Debt/EBITDA 2.96 3.34 1.61 1.71 2.82   2.82
Changes by years, y/y, % -232% -201% -109% -120% -5%    
Changes by quarters, q/q, % -134% +13% -52% +6% +65%    

Intercept Pharmaceuticals. Debt/EBITDA

Intercept Pharmaceuticals. Debt/EBITDA, changes, y/y, %

Intercept Pharmaceuticals. Debt/EBITDA, changes, q/q, %


Have an idea?
Blogs All blogs wire
Most useful
Most commented
NEWS
Trade Signals
Answers to questions
Books reviews
Corporate blogs
Forums All forums wire
Common
Stocks
Algotrading
Options
Cryptocurrencies
Forex
Brokers rating
Stocks Heat Map
Quotes
Fundamental analysis
Financials
Dividends
My portfolio
All companies
Stocks Calendar
Smartlab Smartlab Values
SiteMap
Ads
Contacts

Rules
Help
Feedback
Moscow Exchange is the source and the owner of marketdata. The users haven't right of further distribution or presentation of any data without written permission of Moscow Exchange, haven't right to create modified information for further public distribution to third parties.